WHC est encore en dévelopement. Lisez ceci pour comprendre notre approche.
depiction of AYXYPKUFHZROOJ-UHFFFAOYSA-N.svg
tripsit

pregabalin

Vérifier sur tripsit

psychonaut

Pregabalin

Vérifier sur psychonaut

isomerdesign

Pregabalin

Vérifier sur isomerdesign

pubchem

Pregabalin

Vérifier sur pubchem

druglab

Prégabaline

Vérifier sur druglab

drugmap

Pregabalin

Vérifier sur drugmap

drugmap

Pregabalin

Vérifier sur drugmap

drugmap

Pregabalin

Vérifier sur drugmap

wiki

Pregabalin

Vérifier sur wiki

Data

InChI: InChI=1S/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11)

Synonymes: SR-01000942257-2,SCHEMBL8227,Pregabalin mylan, CCG-40213,CI 1008,KS-5378,148553-51-9,PREGABALIN [MI],Hexanoic acid, 3-(aminomethyl)-5-methyl-, (3S)-,(S)-3-(Aminomethyl)-5-methylhexanoic acid, CA-452, AC1NFWUF,PREGABALIN [USP MONOGRAPH],Pregabalin 1.0 mg/ml in Methanol,pregablin,HSDB 7530,BDBM50164279,121GE001,(3S)-3-(aminomethyl)-5-methylhexanoic acid,CAS-148553-50-8,Lyrica;CI-1008;PD-144723,PD144723, CHEMBL88034,PREGABALIN [JAN],NSC 759256,Q412174,Nervalin, PubChem15652,(3S)-3-(Aminomethyl)-5-methylhexanoic acid,Pregabaline,Pregabalin,CI-1008,(S)-3-(Aminomethyl)-5-methylhexanoicacid,HY-17414,DEA No. 2782, HMS2093F10,(3S)-3-(aminomethyl)-5-methyl hexanoic acid,A808784, TOS-0910,553P508,DTXSID1045950,AKOS005145504, SC-94803,NSC-759256, PD 144550,148553-50-8,Pregabalin, EuropePharmacopoeia (EP) Reference Standard, Pregabalin (controlled-release, oral),SR-01000942257, (3R)-3-(aminomethyl)-5-methylhexanoic acid,PREGABALIN [MART.],(S)-(+)-3-Aminomethyl-5-Methylhexanoic Acid, (R)-3-(Aminomethyl)-5-methylhexanoic acid,Pregablin,CS-1247,DSSTox_RID_81246,D02716, BCP17115,Lyrica (TN), ZINC5760031,(S)-3-aminomethyl-5-methylhexanoic acid,Pregabalina, AC1L2PDQ,DSSTox_CID_25950,NCGC00095186-01,AKOS001476611, 3-(Aminomethyl)-5-methylhexanoicacid, NSC759256, DTXSID90276292, BSPBio_002316,1414928-41-8, NCGC00095186-01, Hexanoic acid, 3-(aminomethyl)-5-methyl-, (3R)-,Pregabalin (JAN/USAN/INN), SCHEMBL263450,(3S)-3-(aminomethyl)-5-methyl-hexanoic acid,3-Aminomethyl-5-methyl-hexanoic acid,Pregabalin zentiva, NSC-759256,GTPL5484, BBL100350,PREGABALIN [ORANGE BOOK], (R)-Pregabalin,3-Isobutyl GABA, rac-Pregabalin,DTXCID9025950,Pregabalin CR,LYRICA CR, Pharmakon1600-01505816,Pregabalin sandoz, 130912-52-6,CCG-221247,Pregabalin- Bio-X,AB01563007_01,PD-144550,(R-)-3-isobutyl GABA, KS-00000AKV, Pregabalin (controlled-release, oral), Pfizer, Hexanoic acid, 3-(aminomethyl)-5-methyl-, CHEMBL167003,PREGABALIN [USP-RS], 128013-69-4,ZINC5152, NCGC00178709-01,PREGABALIN [WHO-DD], SBI-0206875.P001,CHEMBL1059, K-4720,Vronogabic,BP163672,PREGABALIN [EP MONOGRAPH], 3-(aminomethyl)-5-methyl-hexanoic acid,P2840,PD 144723, ACMC-20p1cu,(S)-Pregabalin,Pregabalin [USAN],PREGABALIN [VANDF],NCGC00346738-01, ANW-51583, PD-144550,Pregabalin, >=97% (NMR),MFCD00917044,Hexanoic acid, 3-(aminomethyl)-5-ethyl-, (3S)-, ent-Pregabalin, SPECTRUM1505816,Pregabalin [USAN:INN:BAN:JAN], Hexanoic acid,3-(aminomethyl)-5-methyl-,PD-144723, PHARMA-0589,UNII-55JG375S6M,EN300-92104,55JG375S6M, ACMC-1CF05,(S)-3-Aminomethyl-5-methyl-hexanoic acid,CHEBI:64356,(S)-(+)-4-amino-3-(2-methylpropyl)butanoic acid,PREGABALIN [HSDB],Pregabalin sandoz gmbh, FT-0600823, AKOS027425242, STK894330,Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)-,(S)-3-Isobutyl GABA, R-Pregabalin, BCP05685, FT-0674010,AC-1158,YNP-1807,Z2757554242,3-(aminomethyl)-5-methylhexanoic acid,PREGABALIN [INN], CTK4B5836,lyrica,Tox21_111475, FC0023,3-isobutyl GABA,DB00230,PREGABALIN MYLAN PHARMA,AM20080369, HMS1922H16,DSSTox_GSID_45950, SCHEMBL15497,HMS3715J16,PREGABALIN [EMA EPAR],Lyrica, AYXYPKUFHZROOJ-UHFFFAOYSA-N


Estimated data

Solubility: -0.641 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 61.5% (prediction based on www.mdpi.com)

Similitudes

Voici une série de comparaisons visant à comprendre les propriétés de ce composé. Ce site est encore très expérimental et fait l'objet d'un développement actif. Veuillez vous référer à notre série d'articles d'articles pour bien comprendre notre approche et ses limites. Ces informations sont données à titre indicatif et ne doivent pas être interprétées comme des conseils médicaux.